Glinda (603931): The mid-report performance slightly exceeded expectations, and there are signs of a reversal at the bottom of the fundamentals
Glinda (603931): Significant month-on-month recovery in the second quarter semiconductor developer can be expected in the future
Glinda (603931): The share of semiconductor revenue rises rapidly, and the market can be expected after panel demand reverses
Glinda (603931): TMAH imaging liquid faucet production capacity frees up broad space for domestic alternatives
Glinda (603931): Q3 performance is in line with expectations, product structure optimization enhances profitability
Glinda (603931): Q2 performance exceeds expectations, rich categories and application upgrades bring new momentum for growth
Glinda (603931): High year-on-year growth in 21Q4 performance and continuous upgrading of product application areas
Glinda (603931): The decline in raw material prices improves the application of profitable products and continues to upgrade
Glinda (603931): Product sales increased significantly, and Q3 performance continued to grow
Glinda (603931): Q2 performance is in line with expectations, and the product matrix continues to be rich
Glinda (603931): Continued growth in Q1 performance and significant improvement in profitability
Glinda (603931): Strong production and sales drive up performance, and production capacity under construction provides impetus for growth
Glinda (603931): After 20 years of sharpening a sword, the world's leading TMAH imaging solution wants to take off
Glinda (603931): China's leading supplier of wet electronic chemicals
Gelinda (603931) Approved IPO Strategy Report: China's Leading Wet Electronic Chemicals Manufacturer
Offline Quotation Strategy for Gelinda (603931) IPO
新股网下申购询价建议报告:格林达(603931)、大宏立(300865)、安克创新(300866)
Glinda (603931) IPO RFQ Pricing Report